Timothy R Pearson's Net Worth
$843 Thousand
Who is Timothy R Pearson?
Timothy R Pearson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., GLYCOMIMETICS INC, Ra Pharmaceuticals, Inc., CATALYST HEALTH SOLUTIONS, INC., and Korro Bio, Inc..
SEC CIK
Timothy R Pearson's CIK is 0001528617
Past Insider Trading and Trends
2018 was Timothy R Pearson's most active year for acquiring shares with 6 total transactions. Timothy R Pearson's most active month to acquire stocks was the month of April. 2019 was Timothy R Pearson's most active year for disposing of shares, totalling 9 transactions. Timothy R Pearson's most active month to dispose stocks was the month of December. 2022 saw Timothy R Pearson paying a total of $25,026.00 for 40,400 shares, this is the most they've acquired in one year. In 2019 Timothy R Pearson cashed out on 295,326 shares for a total of $465,825.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TESARO, Inc. No price found
Exec. VP, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.21K |
$75.00 | -$465,825.00 |
0
|
Jan 22
| |||
Form 4
| +112.12% | 3.28K |
$54.86 | -$141,264.50 | 6.21K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
|
∞
| 2.93K |
$177.61 | -$257,001.67 | 2.93K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLYCOMIMETICS INC (GLYC) Snapshot price: $0.1596
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +369.52% | 19.4K |
$1.29 | $25,026.00 | 24.65K |
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 5.25K |
—
|
—
| 5.25K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CATALYST HEALTH SOLUTIONS, INC. No price found
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -40.00K |
—
|
—
|
0
|
Jul 2
| |||
Form 4
| +33.33% | 10K |
—
|
—
| 40K |
Feb 23
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Korro Bio, Inc. (KRRO) Snapshot price: $42.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |